Medidata Spurs Innovation with Developer Central


SYSTEMS INTEGRATION

By Ann Neuer

Nov. 3, 2008Medidata Solutions is launching Medidata Developer Central, an online community to support sponsors in their efforts to integrate various clinical trial solutions with Medidata Rave, the company’s electronic data capture and clinical data management platform. Medidata Developer Central is intended to foster innovation around the Rave platform and is a free service available to users of the recently available Medidata Rave Web Services Application Programming Interface (API), as well as those in the midst of adopting or evaluating Rave Web Services API.

In going live with Medidata Developer Central, Glen de Vries, president, says, “Our customers are demanding the ability to leverage Rave across a broader set of clinical processes by integrating with interactive voice response (IVR), electronic patient reported outcomes (ePRO), and clinical trial management tools. The intent is to maximize and protect their investments in clinical trial technology.”

Glen de Vries
Glen de Vries
The Developer Central community will likely be made up of engineers or product managers responsible for integrating Rave with various technologies. As de Vries explains, developers will have access to a live copy of the Rave platform, searchable documentation, white papers, and guides, essentially all the Web-based tools needed to get started. “While developing at their desks, developers will be able to send data back and forth. You can be testing your own code,” says de Vries.  Members of the community will have an interactive forum where they can converse with and gain access to best practices from developers who are working on the same platform.

Medidata is looking to Developer Central to become a rich community. Over time, the company expects resulting innovations to drive the industry toward a seamless electronic clinical research environment with real-time, inbound and outbound data that adheres to Clinical Data Interchange Standards Consortium (CDISC) data standards. To jumpstart the process, Medidata became certified earlier this year on all eight CDISC Operational Data Model (ODM) use cases for importing and exporting clinical study data. This means that during the integration process, clients have access to Medidata’s ODM standards for all of the various components of their e-clinical process.

During the startup of Developer Central, a number of developers from clinical technology providers stepped forward to become pilot members. One of them, PHT Corp., a provider of ePRO solutions, used the Rave Web Services API to integrate several patient diaries from PHT’s LogPad System into Rave, a demo project that took just six days. Now PHT is aiming to leverage Developer Central’s community and resources to further enhance this solution by making the integration scalable and reliable across a wide range of scenarios.

Philip Lee
Philip Lee
“We did the integration at record pace,” says Philip Lee, president and CEO of PHT. “The old way of integrating would have taken five to 10 times as long as it would have required us to create the electronic case report forms in Rave using their design tool, then we would have had to map their data fields into our database, and then set up the technical mechanism for uploading the data to Rave on a periodic basis.” Lee explains that in addition, the old method required extensive testing, as it constituted a custom integration project.

As integration continues, and with Medidata Developer Central becoming operational, the move toward extensive use of repeatable standards-based processes and forms will expand, saving precious time. “These efforts will greatly accelerate the ability of our clients to get value out of our platform,” says de Vries. 
________________________________

This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.